Vicebio
Vicebio develops next-generation vaccines, focusing on respiratory disease prevention using its Molecular Clamp technology. The company aims to deliver broad protection and ready-to-use formulations. It has a pipeline of multipathogen respiratory vaccines to address global health challenges.
Domain
vicebio.com
Country
United KingdomIndustry
BiotechnologyEmployees
11-50
Last Funding
$100.0M
Founded
2018
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Vicebio use?+
Vicebio uses 15 technologies including Google Tag Manager, Material UI, Font Awesome.
What industry is Vicebio in?+
Vicebio operates in the Biotechnology industry.
Where is Vicebio based?+
Vicebio is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026